K-numberK243165
Device nameLimfa Therapy System (Limfa Therapy)
ApplicantEywa Srl
Product codeNGX
Device classClass II
Decision dateMay 15, 2025
DecisionSubstantially Equivalent
Regulation890.5850
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Limfa Therapy System is a non-invasive medical device that generates pulsed, low-frequency (2-80 Hz) electromagnetic fields to temporarily increase blood circulation in healthy leg muscles and stimulate muscles to improve performance. It consists of a control console and either localized emitters or a full-body mat, and is used in hospitals, physician offices, and home settings.

Technological characteristics

Limfa uses variable bipolar waveforms with ultra-short 1 µs pulses at a 100 kHz carrier frequency, modulated at therapeutic frequencies, achieving up to 190 µT average flux density. The predicate (Bemer) uses fixed monopolar sinusoidal waveforms at 10-30 Hz with 10-33 µs pulse duration and up to 100 µT flux density. Both operate in the ELF range with comparable frequency overlap and intensity ranges, though Limfa offers extended timer flexibility (20-53 minutes vs. 8-20 minutes) and operates at 3 times weekly versus daily use recommendations.

Test standards cited

EN 60601-1, EN 60601-1-2, EN 60601-1-6, EN 60601-1-11, EN 62304, EN 62353, EN 62366, EN ISO 14971, EN ISO 15223-1, IEC 60601-1, IEC 60601-1-2, and IEC TR 60601-4-2 for electromagnetic compatibility, safety, software lifecycle, risk management, and device labeling.

Substantial equivalence argument

Limfa is substantially equivalent because it shares identical indications for use, sites of use, system components architecture, and primary mode of action (non-invasive magnetic field tissue stimulation) with the Bemer predicate devices. Although Limfa employs different waveform generation techniques (variable bipolar modulation versus fixed sinusoidal), both systems deliver low-frequency pulsed electromagnetic stimulation within overlapping and comparable ELF frequency and intensity ranges, raising no new safety or effectiveness concerns. The differences in waveform shape, pulse duration, and timer range are engineering variations that do not alter the fundamental therapeutic objective or create new risks, as all devices comply with the same electrical safety standards (IEC 60601-1) and achieve comparable electromagnetic doses.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →